Colorectal Cancer Canada’s Conferences

Registration is now open! 10th Annual Patient-Centered Approach to Clinical Trials Conference : Canada’s Next Era of Clinical Trials for Patients Begins Now

October 20–21, 2026

Holiday Inn & Suites Montreal Centre-Ville Ouest | Montréal, QC

Canada has the expertise to become a global leader in clinical trials—but patients are still waiting too long to access innovative therapies.

Join us October 20–21 in Montréal for the 10th Annual Patient-Centered Approach to Clinical Trials Conference as patients, healthcare professionals, researchers, policymakers, and industry leaders come together to explore how we can build a faster, more competitive, and patient-centred clinical trials ecosystem.

This year’s conference will focus on what matters most to patients: faster, better access to innovation. As artificial intelligence reshapes every stage of the biopharma lifecycle and global market dynamics continue to evolve, Canada has a unique opportunity to strengthen its clinical trials ecosystem and position itself as a global leader in life sciences.

Conference Highlights

Day One: AI is the Future of Clinical Trials

Explore how artificial intelligence is transforming clinical trials—from early oncology discovery and patient recruitment to drug development and regulatory decision-making. Hear from national and international leaders about how Canada can leverage AI to accelerate innovation and attract global investment.

Featured speakers include:

• Dr. Paul Hébert, President, Canadian Institutes of Health Research (CIHR)
• Rahul G. Krishnan, Canada CIFAR AI Chair, Vector Institute
• Leaders from Bayer, Roche, Montréal InVivo, CATALIS Québec, Quebec International, and more

Day Two: Strengthening Canada’s Clinical Trials System

Discover the practical solutions already underway to improve Canada’s clinical trials environment and accelerate patient access to new therapies. Learn how governments, healthcare institutions, research organizations, and patient groups are working together to modernize the clinical trials landscape.

Hear from experts representing:

• Clinical Trials Ontario
• McGill University Health Centre
• Population Health Research Institute
• Sunnybrook Research Institute
  …and other leading organizations.

Why Attend?

Learn from Canada’s leading experts in clinical trials, AI, and life sciences.
Discover how patients are helping shape the future of clinical research.
Connect with leaders from healthcare, academia, government, patient organizations, and industry.
Be part of the conversation driving Canada’s next era of clinical trials.

October 20–21, 2026

Holiday Inn & Suites Montreal Centre-Ville Ouest | Montréal, QC

Clinical trials are a vital step in the development of new treatments for colorectal cancer patients, and an opportunity for patients to have access to certain treatments earlier than otherwise possible. However, the number of cancer patients enrolled in clinical trials in Canada has for the past few years hovered between two and six percent, despite regular andrecurring interest from patients. Low participation can sink trials, delaying the approval of potentially life-saving drugs. Recognizing this important gap in Canada, CCC has hosted seven annual clinical trials conferences to bring relevant stakeholders together. The goal is to develop a Canadian clinical trials transformation initiative that includes the patient voice in the process.

Access the recordings from past conferences below.